Role of Angiogenesis in Oncology: A Deep Insight into the Mechanistic Aspect

Angiogenesis is the formation of a new vascular system from existing ones and its role in the body's natural physiological and pathophysiological mechanisms. It leads to the beginning and progression of several human problems such as cancer, inflammatory processes, atherosclerosis, and blinding eye diseases in pathologic form. Oncology studies have emphasized inhibiting angiogenesis may be a potential treatment option for some neoplastic diseases. Starting with angiogenesis development, its modulation is followed by vasculature signaling, and the mechanistic exploration of the new vascularisation process is focused on. This review article will focus on the phenomenon of an interface between cancerous cells and their nearby ecosystem, giving the impression of antiangiogenic. However, various anti-angiogenesis drugs that arrest tumor development might not be enough for the eradication of tumors. The blood vessels can also be remodeled by the development, multiplicity, and redundancy of other compensatory mechanisms. Henceforth, novel anticancer strategies will require the identification of broad-spectrum anti-angiogenesis targets and also establishing combination approaches involving antiangiogenic drugs and other anticancer regimes, such as chemotherapeutic agents that may play a vital role in cancer therapeutics.